Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow Print PDF (124K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (17)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Bender, K
Right arrow Articles by Rajewsky, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bender, K
Right arrow Articles by Rajewsky, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1996 Oxford University Press 2087-2094

Footnote

Binding and repair of O 6 -ethylguanine in double-stranded oligodeoxynucleotides by recombinant human O 6 -alkylguanine-DNA alkyltransferase do not exhibit significant dependence on sequence context

Binding and repair of O 6 -ethylguanine in double-stranded oligodeoxynucleotides by recombinant human O 6 -alkylguanine-DNA alkyltransferase do not exhibit significant dependence on sequence context Kirsten Bender , Matthias Federwisch , Ursula Loggen , Peter Nehls and Manfred F. Rajewsky*

Institute of Cell Biology (Cancer Research), University of Essen Medical School, Hufeland-Strasse 55, D-45122 Essen , Germany

Received February 19, 1996; Revised and Accepted April 22, 1996

ABSTRACT

Double-stranded (ds) oligodeoxynucleotides (29mers) containing an O 6 -ethylguanine (O 6 -EtGua) flanked 5 ' and 3 ' by different bases (5 ' ..TGT..3 ' ; 5 ' ..CGG..3 ' , 5 ' ..GGT..3 ' ; 5 ' ..GGG..3 ' ; 5 ' ..GGA..3 ' ) were synthesized to investigate the binding and repair characteristics of recombinant human O 6 -alkylguanine-DNA alkyltransferase (AT) in vitro . The apparent association constant (K A(app) ) of AT to the oligomers and the repair rate constant for O 6 -EtGua (k) respectively, were determined by gel retardation and a monoclonal antibody-based filter binding assay. When ds- or single-stranded (ss) oligomers with or without O 6 -EtGua were used, no major differences in K A(app) values were observed with either substrate: K A(app) values for native AT were 7.1 and 8.4*10 5 M -1 respectively, for unmodified and [O 6 -EtGua]-containing ds-oligomers. The corresponding values for ss-oligomers were 1.0 and 4.9*10 5 M -1 . The N-terminal first 56 amino acids of AT only exert a limited influence on DNA binding; the K A(app) values for an N-terminally truncated AT protein (1.1*10 5 M -1 ) and native AT were of the same order. Moreover, K A(app) was hardly affected by Cys 145 -methylated AT (2.0*10 5 M -1 ). The k-values (6.5-11.5*10 6 M -1 s -1 ) were not significantly dependent on nucleotide sequence. k-values of 5.3 and 4.0*10 6 M -1 s -1 respectively, were obtained with the N-terminally truncated AT protein and for repair of the postreplicative mispair [O 6 -EtGua]: T by native AT. The low K A(app) , the negligible influence on K A(app) guanine-O 6 of ethylation, and the minor modulation of K A(app) and k by varying the bases flanking O 6 -EtGua, all indicate that the binding of AT to DNA is non-specific and mediated mainly by ionic interactions [reduced K A(app) and k-values at increased ionic strength]. Surplus DNA reduces the rate of O 6 -EtGua repair in ds-oligomers by competitive binding of AT molecules. The reaction mechanism of AT with DNA in vivo requires further investigation.

INTRODUCTION

In vitro or in vivo exposure to N-nitrosamides, such as N-ethyl-N-nitrosourea (EtNU) or N-methyl-N-nitrosourea (MeNU), leads to the formation of seven N- and five O-alkylation products (including alkylphosphotriesters) in cellular DNA ( 1 - 3 ). The latter include O 6 -alkylguanines (O 6 -AlkGua) which can cause G:C -> A:T transition mutations ( 4 - 6 ), as observed, e.g., at the central guanine of codon 12 (GGA) of the H-ras gene in rat mammary and skin tumors induced by MeNU ( 7 , 8 ). The relative rate of guanine-O 6 alkylation in DNA upon exposure to a given N-nitrosamide is dependent on sequence context and chromatin structure ( 9 - 12 ). A central guanine is most permissive for O 6 -alkylation by MeNU or EtNU when flanked 5' by a purine, and least permissive when flanked 5' by thymine or 5-methylcytosine ( 9 , 12 ).

O 6 -AlkGua in DNA is repaired by the repair protein O 6 -alkylguanine-DNA alkyltransferase (AT; EC 2.1.1.63; 13 ) and, with increasing size of the alkyl residue, also via the nucleotide excision repair pathway ( 14 ). AT catalyzes the transfer of the alkyl group to Cys 145 at the active site of the protein; the formation of S-alkylcysteine irreversibly inactivates the AT molecule ( 13 ).

The 39 kDa Ada protein, a bacterial AT homolog, contains two cysteine residues active in DNA repair: Cys 321 for O 6 -AlkGua and O 4 -alkylthymines ( 15 ), and Cys 69 for alkylphosphotriesters ( 16 ). Unlike the human and rodent AT proteins, Ada is not inactivated by O 6 -benzylguanine ( 17 ), and its expression is inducible by chronic low-level exposure to alkylating agents (adaptive response; 18 , 19 ). Ogt, a second non-inducible bacterial AT protein is homologous to the C-terminal domain of Ada and the known human and rodent ATs ( 20 ).

All species thus far examined harbor ATs with highly conserved C-terminal amino acid sequences ( 13 , 21 - 23 ). Complete homology is observed around the active center (Pro-Cys*-His-Arg-Val/Ile) ( 24 ). X-ray analysis of the crystal structure of a 178 amino acids fragment of Ada, which includes the active center, has revealed two distinct domains with novel topology ( 25 ). The C-terminal domain contains the active site sequence and, at considerable distance, a `helix-turn-helix variant' DNA-binding motif possibly mediating non-specific binding to DNA. The reactive Cys* lies in a buried position that requires a conformational change of the protein to perform the nucleophilic competition for the target electrophile ( 25 ). Neither DNA-binding motifs nor nuclear localization signals have thus far been described in the amino acid sequences of mammalian AT proteins ( 26 ).

In the present study we have investigated the possible sequence specificity of DNA binding and O 6 -EtGua repair by recombinant human AT (21.7 kDa) before and after mispairing of O 6 -EtGua with thymine during DNA replication. We have used synthetic double-stranded (ds) deoxynucleotides containing a single O 6 -ethylguanine (O 6 -EtGua) flanked by different bases, and active AT, AT inactivated by methyl-group transfer, as well as N-terminally truncated AT (lacking the first 56 amino acids). These analyses complement studies by other groups, probing the immediate vicinity of the substrate binding site and investigating the chemistry of alkyl group transfer with substrate analogs ( 27 - 32 ), as well as studies that have used site-directed mutagenesis to evaluate the role of individual amino acids in the active center of AT ( 33 , 34 ) and elsewhere in the protein ( 35 - 37 ).

MATERIALS AND METHODS

Oligodeoxynucleotides

Oligodeoxynucleotides (29mers) were synthesized on an ABI 381 DNA Synthesizer (Applied Biosystems, Weiterstadt, Germany; Table 1 ). Regular monomer building units were purchased from Applied Biosystems and [O 6 -EtGua]-phosphoramidite from Chemogen (Konstanz, Germany). [O 6 -EtGua]-containing oligomers were deprotected for 72 h at room temperature to avoid the formation of 2,6-diaminopurine ( 38 ). Oligomers were purified by HPLC using reversed-phase cartridges (Nova Pack C-18; Waters, Eschborn, Germany). Elution was performed at a flow rate of 1.5 ml/min (linear gradient; 90% A, 10-100% B in 45 min) with buffers A [100 mM triethylammonium acetate (TEAAc), pH 5.0] and B (100 mM TEAAc, 35% acetonitrile). Fractions with the highest absorption values at [lambda] = 254 nm were collected. To verify the incorporation of O 6 -EtGua, oligomers were enzymatically hydrolyzed to 2'-mono-deoxynucleosides ( 39 ) and analyzed by HPLC.

Annealing and radioactive labeling of oligodeoxynucleotides

Ds-oligomers were generated by incubating [O 6 -EtGua]-containing single-strands with excess (10%) complementary single-strands in a buffer containing 25 mM morpholinopropane sulfonic acid (MOPS), pH 7.4; 0.5 mM EDTA; for 5 min at 50oC, and subsequently for 20 min at 37oC. The temperature was then slowly lowered to 4oC and kept constant overnight. At least >= 90% of oligomers were present in ds-conformation. The strand opposite O 6 -EtGua contained a 5'-protruding end of five bases, to facilitate labeling with [[gamma]- 32 P]ATP ( 40 ).

Expression and purification of recombinant human AT

AT cDNA was cloned from a human liver cDNA library by colony hybridization using published cDNA sequences ( 41 ). Native and truncated AT cDNAs were ligated into the pQE-9 vector (Qiagen, Hilden, Germany, 40), and transfected into Escherichia coli strain M15 (Qiagen). The pQE-9 plasmid encodes a 6 x His-affinity tag (fused to the N-terminus of AT) which can be removed from AT enzymatically.

Bacteria were grown in 2 l of LB medium (100 [mu]g/ml ampicillin and 25 [mu]g/ml kanamycin) at 37oC until an OD 600 = 0.9-1.1 was reached (corresponding to 10-20 mg of AT-protein/l). Protein expression was induced by addition of 100 [mu]M isopropyl-D- thiogalactopyranoside for 2 h. Cells were harvested by centrifugation at 4000 g for 20 min and pellets were stored at -70oC.

Following resuspension in 40 ml buffer A (50 mM NaH 2 PO 4 , Na 2 HPO 4 , pH 8.0; 300 mM NaCl; 10% glycerol; 10 mM mercaptoethanol), bacteria were lysed on ice by sonication. Subsequent operations were carried out at 4oC. To inhibit proteases, 1 mM Pefabloc SC (Boehringer Mannheim, Mannheim, Germany) was added and the solution was centrifuged for 30 min at 30 000 g . The supernatant was applied to a Ni 2+ -nitrilotriacetic acid (Ni-NTA)-agarose column equilibrated with buffer A. After washing with buffer A recombinant AT was eluted with buffer B (50 mM NaH 2 PO 4 , Na 2 HPO 4 , pH 7.6; 200 mM imidazole; 300 mM NaCl; 10% glycerol; 10 mM [beta]-mercaptoethanol). Fractions containing AT were pooled, and the buffer was exchanged on PD-10 columns (Pharmacia-LKB, Freiburg, Germany) equilibrated with buffer C [25 mM MOPS, pH 8.0; 50 mM NaCl; 1 mM EDTA, 10% glycerol; 10 mM dithioerythrol (DTT)]. To remove the His tag, factor Xa (Boehringer Mannheim) was added (20 U/15 mg AT), and the sample was incubated at 0oC for 18 h. Under these conditions >90% of the molecules were cleaved. The sample was sterile-filtered and diluted four times with buffer D (50 mM MOPS, pH 7.1; 20 mM NaCl; 1 mM EDTA; 10% glycerol; 10 mM DTT). The cleavage products were separated on a Mono S column (Pharmacia-LKB). AT was eluted with a linear NaCl gradient (20-400 mM).

The specific activity of recombinant AT for repair of O 6 -EtGua was determined as the ratio of the concentration of active AT, as resulting from the kinetic analyses, and the total AT concentration, as measured photometrically using [epsilon] = 28 900 M -1 cm -1 at [lambda] = 280 nm. The specific activity of AT was calculated to be [approx]60%; it remained constant for months when the AT protein was stored at -70oC.

Forty percent of inactive (non-methylated) AT-protein does not interfere with the repair process because AT remains monomeric in solution ( 44 ; and our own results) and, according to the law of mass action and the low concentrations of oligomers and AT (Fig. 1 ), the frequency of AT-oligomer complexes is very low. Hence, the probability of two AT molecules competing for one oligomer tends towards zero.


Figure 1 . Determination of the rate constant, k, for repair of O 6 -EtGua by recombinant human AT. Increasing concentrations (20-100 pM) of an [O 6 -EtGua]-containing ds-oligomer (29mer) (5'...G G A...3' * 3'...CCA...5'; Table 1) were incubated with the AT protein (18 pM) for 60 min at 37oC (see Materials and Methods). The values represented by filled circles were used for calculation of the repair rate constant (k = 7.6 * 10 6 M -1 s -1 ).

N-terminally truncated AT (amino acids 1-56), generated by site-directed mutagenesis ( 40 ), formed inclusion bodies exclusively and had to be purified under denaturating conditions. To prepare Cys 145 -methylated AT, the purified AT were incubated with O 6 -guanine methylated calf thymus DNA. Ni 2+ -chelate chromatography was then used to remove DNA. Further steps were as described for native AT.

Immunoanalytical determination of the repair rate constant for O 6 -EtGua (k)

Constant amounts of native or modified AT (20 pM) were incubated for 1 h at 37oC with increasing amounts (10-100 pM) of 32 P-labeled, [O 6 -EtGua]-containing ds-oligomers in a total volume of 100 [mu]l [50 mM Tris-HCl, pH 7.6; 10 mM DTT; 1 mM EDTA; and 200 [mu]g/ml bovine serum albumin (BSA)]. The repair reaction was stopped by adding 10 [mu]l 1 M NaCl and an excess (10 [mu]g) of anti-[O 6 -ethyl-2'-deoxyguanosine] monoclonal antibody (MAb) ER-6 ( 42 ). After incubation for 1 h at room temperature, [O 6 -EtGua]-oligomer-Mab complexes were separated from repaired oligomers by filtration through pieces of nitrocellulose membrane BA 85 (Schleicher & Schuell, Dassel, Germany). Membranes were washed twice with 2 ml buffer (50 mM Tris-HCl, pH 7.6; 1 mM EDTA; 100 mM NaCl). [O 6 -EtGua]-containing oligomers complexed to the MAb retained on the filter were quantified by determining their 32 P-radioactivity in 4 ml scintillation cocktail (Ready Safe; Beckman, Munich, Germany) in a liquid scintillation spectrometer (Wallac; Pharmacia-LKB).

Because reaction with O 6 -EtGua in DNA inactivates the AT molecule, repair by AT follows second-order kinetics. The repair rate constant, k, and the initial concentration of active AT were determined by means of an iterative computer program ( 43 ; available from P. Nehls).

To examine the influence of ionic strength (NaCl concentration) on k, the initial repair rate constants, k i , which approximate k within the limits of short reaction times, were determined ( 44 ). The influence on k of increasing concentrations of calf thymus DNA, plasmid DNA (3.4 kb), or ds-oligomers was also investigated.

Gel retardation assay

Constant amounts of 32 P-labeled unmodified or [O 6 -EtGua]- containing oligomers (300 pM) were incubated for 30 min at 4oC with increasing amounts of native AT, N-terminally truncated AT or Cys 145 -methylated AT (0.2-20 [mu]M), in 50 mM Tris-HCl, pH 7.6; 10 mM DTT; 1 mM EDTA; and 200 [mu]g/ml BSA. Free oligomers were separated from protein-bound oligomers by electrophoresis on 4% polyacrylamide gels (TBE-buffer system; 40 ) at 100 V for 1 h at 4oC. All buffers were cooled to 4oC before use. After electrophoresis, gels were vacuum dried, cut into slices, and analyzed by liquid scintillation spectrometry to determine the ratio of free to AT-bound oligomers.

Determination of K D(app) and K A(app)

Apparent dissociation constants, K D(app) , for the interaction of oligomers with native or modified AT were determined by fitting the experimental data to the equation: KD(app) = (f x B0) / (1 - f) ( 1 )

where f is the fraction of free oligomer, and B 0 is the initial AT concentration ( 45 ).

The number of base pairs (bp), n, involved in the binding of AT was determined by a Scatchard plot v/L [mol/l] against v. v represents the `binding density' [mol of bound protein/mol of total oligomer bases], i.e. mol of bound oligomer/mol of oligomer multiplied by the number of bases. Since the concentration of L, free AT, largely exceeded that of the oligomer, L approximated B 0 at equilibrium.

If the ligand covers >= 2 bp and potential binding sites overlap, the slopes and intercepts of this plot take on meanings different from those originally introduced by Scatchard ( 46 ). The intercept on the v/L axis is equal to the intrinsic dissociation constant, K i , and within the limits of low binding density the slope of the line, b, is equal to -K i (2n - 1). Analyzing a finite oligomer instead of an infinite lattice, the correction factor is approximately (N - n + 1)/N (N being the number of base-pairs per oligomer). The dissociation constant per binding site, K D , is the product of K i and n. The apparent association constant K A(app) is 1/K D(app) . K D(app) values were determined by the program Sigma Plot (Jandel Scientific, Erkrath, Germany).

RESULTS

Kinetic analyses and repair rate constants

Ds-oligomers (29mers) were used to determine the rate constants for repair of O 6 -EtGua by recombinant human AT as a function of DNA sequence context. DNA sequences were designed to represent all possible combinations of purines and pyrimidines flanking a single O 6 -EtGua residue. Since ions reduce repair rates, measurements were carried out at low ionic strength. For determination of the repair rate, AT was incubated for 1 h at a constant concentration with varying concentrations of a given oligomer. This experimental alternative to conventional kinetic analysis has previously been used by Dolan et al . ( 47 ). Its advantage is that both k and the concentration of active AT can be determined simultaneously by computer. A representative curve is shown in Figure 1 .

Repair rate constants were not significantly influenced by the nature of the bases flanking the O 6 -EtGua residue, with k-values ranging between 6.5 and 11.5 * 10 6 M -1 s -1 (Table 1 ). When paired with thymine, O 6 -EtGua was repaired at a slightly lower rate (4.0 * 10 6 M -1 s -1 ), but this difference is statistically not significant. The 6* His tag did not influence repair rates (Table 1 ). N-terminal truncation of the AT molecule did not markedly influence the k-value (5 * 10 6 M -1 s -1 ). Moreover, as native AT, the truncated AT was inactivated by O 6 -benzylguanine (data not shown). Increasing the NaCl concentration from 10 to 100 mM reduced the log k i value from 6.9 to 5.8. Similary, the addition of surplus DNA resulted in lower log k i values (data not shown).

Table 1 . Ds-oligodesoxynucleotides containing a single O 6 -EtGua flanked by different bases: rate constants, k, for repair by recombinant human AT
Oligonucleotide sequence a

Repair rate constant (k)

* 10 -6 [M -1 s -1 ]

5'...T G T ...3'

10.6 +- 4.5 1

3'...ACA...5'

5'...C G G...3'

9.7 +- 1.0 2

3'...GCC...5'

5'...G G T...3'

6.5 +- 1.3 3

3'...CCA...5'

5'...G G G...3'

10.3 +- 2.3 4

3'...CCC...5'

5'...G G A...3'

11.5 +- 5.6

3'...CCT...5'

5'...G G A...3'

4.0 +- 1.7 5

3'...CTT... 5'

5'...C G G...3'

5.3 b

3'...GCC...5'

5'...C G G...3'

10.3 c

3'...GCC...5'

a All ds-oligodeoxynucleotides are derived from the sequence: 5'-A CTG ACT GAT GTT TGT X G X GAC TGA CTG-3'. The bold one-letter symbol ( G ) corresponds to O 6 -EtGua. Repair rate constants, with standard deviations, were determined as described in Materials and Methods. Differences between means and the maximum value (11.5 M -1 s -1 ) were analyzed by Student's test; P values are <0.05 1 and >0.05 2-5 . b Truncated AT protein, lacking the first N-terminal amino acids. c AT carrying the His tag.

The repair of O 6 -AlkGua in DNA by AT requires several steps: recognition and binding of the alkyl group on the O 6 -atom of guanine, and its transfer to Cys 145 of AT. To identify the rate limiting step, the DNA concentration was increased at a constant ratio of O 6 -EtGua/Gua (data not shown). At low DNA concentrations (0-60 nM deoxynucleotides) k-values increased in parallel to DNA concentration. If at constant AT concentration alkyl group transfer were the rate-limiting step, then the apparent repair rate would be the product of k multiplied by the substrate concentration. In contrast, when the repair rate is reduced at DNA concentrations >60 mM, alkyl group transfer will no longer be rate limiting. Rather, due to the law of mass action, a larger proportion of AT molecules become bound to unmodified DNA and the overall repair activity of AT is thus reduced. To test for this effect of competitive binding, surplus ds-DNA molecules of different lengths (29mers; plasmid DNA of 3.4 kb; calf thymus DNA) were added to the samples. The extent of inhibition proved to be dependent only on the molar concentration of base pairs, not on the lengths of the DNA molecules added (data not shown). Thus, in the presence of a large excess of DNA recognition and binding of the alkyl group become rate limiting ( 48 ).

The recognition of O 6 -alkyl groups could be facilitated by lateral diffusion of AT molecules on the DNA surface; i.e., AT initially diffuses to DNA, binds nonspecifically and then rapidly `scans' adjacent sites until the alkyl group is located, or just dissociates from DNA. The scanning of an AT molecule of DNA would resemble the movement along a continuous cylinder. This should be reflected by the behaviour of k as a function of ionic strength ( 48 ). If there were purely electrostatic interaction, ions would be expected to exert a shielding effect, resulting in a linear relation between log k and log [NaCl] in the 29mers. This is indeed the case (log-log plots not shown). Plotting published data (fig. 7 in ref. 44 ) for O 6 -methylguanine (O 6 -MeGua) in calf thymus DNA in the same way also results in a near-linear relation with the same slope and almost identical k-values.

Binding studies

The K A(app) for the binding of AT to DNA was determined by a quantitative gel retardation assay (see Materials and Methods). Two methods were used for the analysis of the data (see Materials and Methods; Fig. 2 A and B). The results were equal within a factor of 2, with differences varying statistically. The data obtained using equation 1 are shown in Tables 2 and 3 .


Figure 2 . ( A ) Determination of the apparent association constant (K A(app) ) of recombinant human AT with [O 6 -EtGua]-containing ds-oligomers. Determination of the K A(app) value for the binding of purified recombinant human AT to 32 P-labeled ds-oligodeoxynucleotides containing a single O 6 -EtGua ( G ) in the sequence 5'...C G G...3' (see Table 1). The fraction of free oligomers, as quantified by gel retardation assay, was plotted as a function of AT concentration. Increasing amounts of AT protein were incubated with 6 fmol of ds-oligomer in a total volume of 20 [mu]l for 30 min at 4oC (see Materials and Methods). Samples were loaded on native polyacrylamide gels and DNA oligomers were separated from bound AT by electrophoresis (100 V; 60 min; 4oC). The fractions of free DNA molecules as determined by liquid scintillation spectrometry were used for calculation of K A(app) (8.4 * 10 5 M -1 ). Inset: Autoradiogram gel-retardation gel. ( B ) Determination of the intrinsic association constant, K i , and the number of base pairs, n, involved in AT binding. v represents the binding density (mol of bound oligomer/mol of oligomer multiplied by the number of bases) and L is the concentration of free protein. The data were taken from Figure 2A. The intercept on the v/L axis, K i ', is equal to 25.4 * 10 3 M -1 . The slope of the line, b, is equal to 0.84 * 10 6 M -1 . n = (-b/K i ' + 1)/2 = 17. Correction of K i ' for the finite length of the oligomer yields: K i = 25.4 * 10 3 M -1 * [29/(29 - 17 + 1)] = 56.7 * 10 3 M -1 . Recalculation of n yields n = 7.9. K A(app) per oligomer is equal to n * K i = 4.5 * 10 5 M -1 .


Figure 3 . Binding of AT to 32 P-labeled ds-oligonucleotides with or without O 6 -EtGua, in the presence of increasing NaCl concentrations. Purified AT protein (4.5 [mu]M) was incubated with ds-oligomer [with (-) or without ([squf]) O 6 -EtGua in the sequence 5'...C G G...3'; see Table 1) and increasing amounts of NaCl (20-1000 mM) for 10 min at 4oC in a total volume of 20 [mu]l. The fractions of free oligomers were determined after separation from protein-bound DNA molecules on a native 4% polyacrylamide gel (see Materials and Methods and Fig. 2A).

Table 2 . K A(app) values for the interaction of recombinant human AT with various oligomers
Oligomers a

Apparent association constant of AT

K A(app) * 10 -5 [M -1 ]

ds (O 6 -EtGua)

8.4 +- 2.4 b

ds (Gua)

7.1 +- 2.4 b

ss (O 6 -EtGua)

4.9 +- 2.0 b

ss (Gua)

1.0 +- 0.4 b

a Bases flanking O 6 -EtGua in the oligodeoxynucleotides were: 5'...C G G...3' (see Table 1). K A(app) values were calculated as described Materials and Methods (see also Fig. 2A). b Standard deviations. Differences between means and the maximum value (8.4 * 10 5 M -1 ) were analyzed by Student's test: All P values are >0.05.

Table 3 . K A(app) values for the interaction of recombinant human AT and its derivatives with a ds-oligomer containing O 6 -EtGua
AT and AT-derivatives

Apparent association constant a

K A(app) * 10 -5 [M -1 ]

Full length AT

8.4 +- 2.4

Cys 145 -methylated AT

2.0 +- 0.3

N-terminally truncated AT

1.1 b

a For further details, see Table 2. b Due to the limited material available the experiment was carried out only once (K A(app) not corrected for the fraction of unrepaired oligomers; see Results). Mean values were analyzed by Student's test: P > 0.05.

The binding of recombinant AT to ds 29mers was not affected by the presence or absence of an O 6 -EtGua residue [K A(app) = 8.4 * 10 5 M -1 and 7.1 x 10 5 M -1 , respectively; Table 2 ). In analyzing the binding of AT to [O 6 -EtGua]-containing oligomers, it had to be considered that under the conditions of the band-shift assay [approx]40% of labeled oligomers remained unrepaired prior to application to the gel (data not shown); the K A(app) values were corrected accordingly. The negligible influence of the O 6 -ethyl group on the K A(app) is reflected by the observation that the binding affinity of AT to modified and unmodified oligomers was reduced to a very similar extent when the NaCl concentration was increased (Fig. 3 ). However, non-specific binding of AT to O 6 -EtGua should be affected by increasing ionic strength more strongly than specific binding ( 49 ). Moreover, log-log plotting of the fraction of free oligomers as a function of Na + concentration results in a straight line (data not shown), confirming that the binding of AT to the oligomers is non-specific. Analysis of the gel retardation data according to McGhee and von Hippel ( 46 ) indicates that 8-10 bp are involved in AT binding (Fig. 2 B).

Compared with the K A(app) values for [O 6 -EtGua]-containing ds-oligomers, K A(app) for [O 6 -EtGua]-containing ss-oligomers was reduced by a factor of 1.7 (Table 2 ); the difference of K A(app) values for ss-oligmers with and without O 6 -EtGua was hardly significant. K A(app) for the binding of N-terminally truncated AT to ds-oligomers containing O 6 -EtGua was about seven times lower (1.1 * 10 5 M -1 ) than K A(app) for native recombinant AT (Table 3 ). Cys 145 -methylated AT protein bound to [O 6 -EtGua]-containing ds-oligomers with a K A(app) of 2.0 * 10 5 M -1 (Table 3 ).

DISCUSSION

Unrepaired O 6 -AlkGua in DNA can cause G:C -> A:T transition mutations by misreplication ( 5 ). The probability of O 6 -AlkGua formation in DNA by N-nitrosamides (MeNU, EtNU) is dependent on sequence context ( 12 ). Alkylation on guanine-O 6 is favored when a central guanine is flanked 5' by a purine; 5' thymine and 5-methylcytosine have the opposite effect ( 9 - 12 , 50 ). In the present study, we have investigated whether the efficiency of repair of O 6 -AlkGua by AT is similarly influenced by the sequence context. Ds-oligomers (29mers) containing a single O 6 -EtGua flanked by different neighboring bases within an otherwise constant sequence context were used as substrates for recombinant human AT.

Since short oligodeoxynucleotides (<10 bp) are repaired by AT at a lower rate ( 51 , 52 ) the ds-oligomers used in this study were 29 nt in length; i.e., close to three helical turns. This is sufficient for AT binding, which requires 8-10 bp, and ensures that the oligomers remain double-stranded at 37oC (Table 1 ). Because the Z-DNA conformation is inhibitary for AT ( 53 ), a random oligomer sequence was chosen to insure the B-conformation.

The rate constants for repair of O 6 -EtGua by AT ranged from k = 4.0-11.5 * 10 6 M -1 s -1 . Similar k-values have been published by others ( 54 ). The second-order association rate constant for a 203 bp lac DNA fragment with its repressor is ~4 * 10 9 M -1 s -1 ( 48 ). This association is only limited by diffusion. The repair of O 6 -EtGua by AT must, therefore, be slowed down by other mechanisms. k-values were not significantly affected by sequence context. The postreplicative [O 6 -EtGua]:T base-pair was a good substrate for recombinant human AT, too.

Using HT29 cell extracts, Dolan et al . ( 50 ) observed only a slight sequence dependence of k-values for repair of O 6 -MeGua. Repair rate constants were of the order of 0.1 * 10 6 M -1 s -1 . This low value is probably due to the use of shorter self-complementary oligomers (12mers). k-values for repair of O 6 -MeGua by Ada and mammalian ATs varied by a factor of 4 at most when a 5' flanking guanine was exchanged for adenine in the 12mers ( 10 ).

In contrast, Georgiadis et al . ( 56 ), using Ada and [O 6 -MeGua]- containing ds-oligomers, reported k-values varying by factors of <= 20 depending on sequence context. This is the only report indicating a strong influence of nearest neighbors; even next-neighbor effects were detected. The k-values published by these authors are 1 or 2 orders of magnitude lower than those reported by others ( 13 , 50 ) and those determined in the present study.

Interestingly, the Ada protein, contrary to AT, is insensitive to inactivation by O 6 -benzylguanine ( 17 , 57 , 58 ). This has been attributed to a steric restriction of the Ada binding site and may explain the observation that the differences between k-values for repair of O 6 -MeGua versus O 6 -EtGua are far greater with Ada than with mammalian ATs ( 13 ). Moreover, K A(app) for DNA binding is an order of magnitude higher for Ada than for human AT ( 59 ).

Gaffney and Jones ( 60 ) have published a thermodynamic comparison of base pairs varying the base opposite O 6 -MeGua. The relative order of stability was C > A > G > T. Variation of nearest-neighbors covered a much smaller range in T max (within 1o of T m of the oligomer) than the different base-pairs, and showed little sequence dependence. Hence, no significant influence of nearest-neighbors is to be expected from a thermodynamic point of view.

The influence of Ada on mutational spectra has been measured in adapted and non-adapted E.coli carrying the pSV2gpt plasmid following exposure to N-methyl-N'-nitro-N-nitrosoguanidine ( 61 ). The distribution of mutations in the coding region of the hprt gene has been compared in human fibroblasts with intact AT activity and after inhibition of AT by O 6 -benzylguanine ( 62 ). In all of these studies nearly identical results were obtained: (i) the same types of mutations; (ii) the same sequence specificity of mutagenesis; and (iii) occurence of the the majority of mutations in the coding DNA strand. Similar results were obtained with MeNU ( 63 ).

The reduction of AT repair activity in vitro in the presence of excess of unmodified DNA is well documented ( 44 , 64 ). With the present [O 6 -EtGua]-containing ds-oligomers, inhibition of AT by unmodified DNA sequences is negligible due to the high ratio of O 6 -AlkGua residues to normal base-pairs. Here, transfer of the alkyl group to Cys 145 in AT is rate-limiting in the repair process. With increasing concentrations of surplus unmodified DNA, the recognition and binding of O 6 -AlkGua become rate-limiting due to competitive DNA binding.

How then are relatively few O 6 -AlkGua residues recognized by AT molecules in the presence of a large excess of DNA not containing this alkylation product? Does AT diffuse directly and freely to the target or rather act in a processive manner, i.e., by lateral diffusion of AT molecules on DNA? Provided the recognition and binding of the O 6 -alkyl group on guanines by AT are rate-limiting, a model elaborated by Winter et al . ( 48 ) may be applied. In a two-step process, AT would bind to DNA weakly and non-specifically, and then scan DNA for O 6 -AlkGua residues by lateral diffusion. This facilitated search would compensate for the competition by intact DNA. The effect would become less pronounced with short DNA sequences, and disappear in the case of oligomers. However, there is no evidence for lateral diffusion of AT (see above; and fig. 7 in ref. 44 ): (i) the k-value for O 6 -MeGua in ds-DNA ( 44 ) is as low as the values determined here for O 6 -EtGua in oligomers. Hence, there is no kinetic gain from long stretches of DNA; (ii) surface sliding would cause a complex dependence of k on ionic strength as illustrated by Winter et al . (fig. 2 in ref. 48 ). In reality, there is an approximately linear relation between log k and log [NaCl] in the case of oligomers and ds-DNA. Hence, binding of AT to DNA appears to be random and AT molecules presumably `jump' from one binding site to the next without lateral diffusion.

The K A(app) values obtained in the present study are in good agreement with those calculated by Chan et al . ( 65 ) for the interaction of human AT with unmodified ds-DNA (4.7 * 10 5 M -1 ). A similar value (9 * 10 5 M -1 ) has been reported by these authors for the binding of AT to DNA reacted with MeNU though `most' of the O 6 -MeGua residues were removed under their assay conditions.

The present experiments have shown that AT does not bind specifically to O 6 -EtGua residues in DNA, and that increased NaCl concentrations do not enable AT to discriminate between modified or unmodified oligomers. Analyses of our quantitative gel retardation data according to McGhee and von Hippel ( 46 ) revealed that 8-10 bp are involved in AT binding, in agreement with published results ( 25 , 65 ). The binding affinity of AT to ss-oligomers was slightly reduced in comparison to ds-oligomers. The preferential repair of ds-DNA ( 55 ) may be due to a differential presentation of O 6 -EtGua in ds- versus ss-DNA. AT inactivated by methyl group transfer to Cys 145 exhibited nearly unchanged binding affinty to native DNA (Table 3 ), in agreement with earlier studies indicating that the binding of human AT to DNA is not affected by the methylation status of the active center ( 44 ), and with the prediction that no major conformational changes should occur upon alkylation of the Ada protein ( 25 ).

X-ray analyses of the crystal structure of the C-terminal half of Ada, which contains the active center, have revealed that this part of the molecule consists of two domains ( 25 ), the C-terminal domain being highly conserved ( 24 ). Removal of 36, but not of 31, C-terminal amino acids from human AT led to a complete loss of repair activity ( 66 - 68 ). A 14-amino acid peptide carrying the active site of AT (Lys-Val-Pro-Ile-Leu-Ile-Pro-Cys*-His-Arg-Val-Val-Cys-Ser) did not eliminate alkyl groups from the O 6 -atom of guanine in DNA (our unpublished data), suggesting that a correctly folded C-terminal domain is a prerequisite for catalytic activity.

The N-terminally truncated AT (amino acids 1-56) used in the present study showed a 7-fold lower affinity for [O 6 -EtGua]- containing ds-oligomers than native AT, and a 2-fold lower affinity compared with Cys 145 -methylated AT. However, the repair rate constant, k, was not affected by N-terminal truncation. The N-terminal amino acid sequence is not conserved to the extent found in the C-terminal domain ( 24 ). The N-terminal domain of AT may thus not be essential for repair, and its function remains unclear. It might contain recognition sequences for other nuclear proteins, and, in eukaryotic cells, be responsible for the translocation of AT to the nucleus. Nuclear localization sequences of AT have thus far not been detected ( 26 ); however, Ada expressed at high levels in NIH-3T3 cells is not efficiently transported into the nucleus ( 69 ), possibly due to differences in the N-terminal domains of Ada and AT. The simplest function of the N-terminal domain may be to keep the AT molecule soluble: a hydrophilicity plot shows that primarily the first 45 amino acids are hydrophilic ( 70 ). While in E.coli about half of the native recombinant AT molecule carrying the His tag are expressed in soluble form (the other half as inclusion bodies), the N-terminally deleted AT protein forms inclusion bodies exclusively. This is in accordance with Crone et al. ( 68 ) who reported that N-terminal deletion of 10 or 19 amino acids led to a significant reduction of recombinant AT repair activity in E.coli cell extracts, due to a substantial decrease in the amount of AT protein: most of the AT protein had probably formed insoluble inclusion bodies.

In conclusion, the DNA binding affinity of recombinant human AT is low, non-specific, and mainly due to ionic interactions, hardly permitting a distinction between guanine alkylated in the O 6 -position and its intact counterpart. No DNA-binding motifs have thus far been detected in the primary sequence ( 26 ). The folding pattern of the C-terminal domain of Ada reveals a `helix-turn-helix variant' which is far away from the active center of the protein; it is not clear whether this motif mediates generalized binding to DNA ( 25 ). Binding of AT to DNA appears to be random; since AT molecules are incapable of migrating along DNA, they presumably `jump' from one binding site to another. If a binding site carries an O 6 -AlkGua, it is repaired at once. Since both the recognition and binding of AT to O 6 -AlkGua in DNA are rather inefficient, they may be mediated by other proteins in vivo . Binding to damage recognition proteins could be a function of the N-terminal part of AT. Such interactions might result in differential repair of O 6 -EtGua in transcribed and nontranscribed gene sequences ( 71 ) and account for some sequence specificity in vivo . Factors targeting AT to O 6 -alkylation products in the DNA of transcriptionally active genes (e.g., transcription repair coupling factor; 72 ) have not yet been identified in mammalian cells, but are worth looking for.

ACKNOWLEDGEMENTS

This work was supported by Dr Mildred Scheel Stiftung für Krebsforschung (W 87-92 Ra5) and Deutsche Forschungsgemeinschaft (SFB 354). We are indebted to Mrs Anke Galhoff for excellent technical assistance; to Dipl.-Ing. Klaus Lennartz for installation of the computer program, and to a referee for helpful comments.

REFERENCES

1 Singer, B., Bodell, W.J., Cleaver, J.E., Thomas, G.H., Rajewsky, M.F. and Thon, W. (1978) Nature, 276, 85-88. MEDLINE Abstract

2 Beranek, D.T., Weis, C.C. and Swenson, D.M. (1980) Carcinogenesis, 1, 595-606.

3 Singer, B. and Grunberger, D. (1983) Molecular Biology of Mutagens and Carcinogens. Plenum Press, New York.

4 Loveless, A. (1969) Nature, 223, 206-207. MEDLINE Abstract

5 Loechler, E.L., Green, C.L. and Essigmann, J.M. (1984) Proc. Natl Acad. Sci. USA, 81, 6271-6275. MEDLINE Abstract

6 Swann, P. (1990) Mutation Res., 233, 81-94.

7 Zarbl, H., Sukumar, S., Arthur, A.V., Martin-Zanka, D. and Barbacid, M. (1985) Nature, 315, 382-385. MEDLINE Abstract

8 Brown, K., Buchmann, A. and Balmain, A. (1990) Proc. Natl Acad. Sci. USA, 87, 538-542. MEDLINE Abstract

9 Rajewsky, M.F. and Nehls, P. (1987) In Chagas, C. and Pullmann, B. (eds) Molecular Mechanisms of Carcinogenic and Antitumor Activity. Pontificiae Academiae Scientiarum Scripta Varia, 70, Vatican and Adenine Press, pp. 131-146.

10 Pegg, A.E. and Dolan, M.E. (1989), In Lambert, M.W. and Laval, J. (eds) DNA Repair Mechanisms and their Biological Implications in Mammalian Cells. Plenum Press, New York, pp. 45-59.

11 Richardson, F.C. and Richardson, K.K. (1990) Mutation Res., 233, 127-138.

12 Sendowski, K. and Rajewsky, M.F. (1991) Mutation Res., 250, 153-160.

13 Pegg, A.E. and Byers, T.L. (1992) FASEB J., 6, 2302-2310. MEDLINE Abstract

14 Bootsma, D. and Hoeijmakers, J.H.J. (1994) Mutation Res., 307, 15-23.

15 Demple, B., Sedgwick, B., Robins, P., Totty, N., Waterfield, M.D. and Lindahl, T. (1985) Proc. Natl Acad. Sci. USA, 82, 2688-2692. MEDLINE Abstract

16 Sedgwick, B., Robins, P., Totty, N. and Lindahl, T. (1988) J. Biol. Chem., 263, 4430-4433. MEDLINE Abstract

17 Elder, R.H., Margison, G.P. and Rafferty, J.A. (1994) Biochem. J., 298, 231-235. MEDLINE Abstract

18 Samson, L. and Cairns, J. (1977) Nature, 267, 281-282. MEDLINE Abstract

19 Lindahl, T. and Sedgwick, B. (1988) Annu. Rev. Biochem., 57, 133-157. MEDLINE Abstract

20 Potter, P.M., Wilkinson, M.C., Fitton, J., Brennand, J., Cooper, D.P. and Margison, G.P. (1987) Nucleic Acids Res., 15, 9177-9193. MEDLINE Abstract

21 Demple, B. (1990) In Paik, W.K. and Kim, S. (eds) Protein Methylation. CRC Press, Boca Raton, pp. 285-304.

22 Basu, A.K. and Essigmann, J.M. (1990) Mutation Res., 233, 189-201.

23 Mitra, S. and Kaina, B. (1993) Progr. Nucleic Acids Res. Mol. Biol., 44, 109-142.

24 Rafferty, J.A., Elder, R.H., Watson, A.J., Cawkwell, L., Potter, P.M. and Margison, G.P. (1992) Nucleic Acids Res., 20, 1891-1895. MEDLINE Abstract

25 Moore, M.H., Gulbis, J.M., Dodson, E.J., Demple, B. and Moody, P.C.E. (1994) EMBO J., 13, 1495-1501. MEDLINE Abstract

26 Santibanez-Koref, M., Elder, R.H., Fan, C.Y., Cawkwell, L., McKie, J.H., Douglas, K.T., Margison, G.P. and Rafferty, J.A. (1992) Mol. Carcinogenesis, 5, 161-169.

27 Spratt, T.E. and de los Santos, H. (1992) Biochemistry, 31, 3688-3694. MEDLINE Abstract

28 Moschel, R.C., McDougall, M.G., Dolan, M.E., Stine, L. and Pegg, A.E. (1992) J. Med. Chem., 35, 4486-4491. MEDLINE Abstract

29 Arris, C.E., Bleasdale, C., Calvert, A.H., Curtin, N.J., Dalby, C., Golding, B.T., Griffin, R.J., Lunn, J.M., Major, G.N. and Newell, D.R. (1994) Anti-Cancer Drug Design, 9, 401-408.

30 Spratt, T.E. and Campbell, C.R. (1994) Biochemistry, 33, 11364-11371. MEDLINE Abstract

31 Chae, M.Y., McDougall, M.G., Dolan, M.E., Swenn, K., Pegg, A.E. and Moschel, R.C. (1994) J. Med. Chem., 37, 342-347. MEDLINE Abstract

32 Chae, M. Y., Swenn, K., Kanugula, S., Dolan, M.E., Pegg, A.E. and Moschel, R.C. (1995) J. Med. Chem., 38, 359-365. MEDLINE Abstract

33 Ling-Ling, C., Nakamura, T., Nakatsu, Y., Sakumi, K., Hayakawa, H. and Sekiguchi, M. (1992) Carcinogenesis, 13, 837-843.

34 Ihara, K., Kawate, H., Chueh, L.-L., Hayakawa, H. and Sekiguchi, M. (1994) Mol. Gen. Genet., 243, 379-389. MEDLINE Abstract

35 Crone, T.M., Goodtzova, K., Edara, S., and Pegg, A.E. (1994) Cancer Res., 54, 6221-6227. MEDLINE Abstract

36 Pieper, R.O., Morgan, S.E. and Kelly, M.R. (1994) Carcinogenesis, 15, 1895-1901. MEDLINE Abstract

37 Rafferty, J.A., Tumelty, J., Skorvaga, M., Elder, R.H., Margison, G.P. and Douglas, K.T. (1994) Biochem. Biophys. Res. Commun., 199, 285-291. MEDLINE Abstract

38 Smith, L.A., Xu, Y.Z. and Swann, P.F. (1990) Carcinogenesis, 11, 811-816. MEDLINE Abstract

39 Müller, R. and Rajewsky, M.F. (1980) Cancer Res., 40, 887-896. MEDLINE Abstract

40 Sambrook, J, Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual. 2nd Edition, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.

41 Tano, K., Shiota, S., Collier, J., Foote, R.S. and Mitra, S. (1990) Proc. Natl Acad. Sci. USA, 87, 686-690. MEDLINE Abstract

42 Rajewsky, M.F., Müller, R., Adamkiewicz, J. and Drosdziok, W. (1980) In Pullman, B., Ts'o, P.O.P. and Gelboin, H. (eds) Carcinogenesis: Fundamental Mechanisms and Environmental Effects. Reidel, Dordrecht, pp. 207-218.

43 Nehls, P. and Rajewsky, M.F. (1990) Carcinogenesis, 11, 81-87. MEDLINE Abstract

44 Bhattacharyya, D., Foote, R.S., Boulden, A.M. and Mitra, S. (1990) Eur. J. Biochem., 193, 337-343. MEDLINE Abstract

45 Castaing, B., Geiger, A., Seliger, H., Nehls, P., Laval, J., Zelwer, C. and Boiteux, S. (1993) Nucleic Acids Res., 21, 2899-2905. MEDLINE Abstract

46 McGhee, J.D. and von Hippel, P.H. (1974) J. Mol. Biol., 86, 469-489. MEDLINE Abstract

47 Dolan, M.E., Scicchitano, D. and Pegg, E. (1988) Cancer Res., 48, 1184-1188. MEDLINE Abstract

48 Winter, R.B., Berg, O.G. and von Hippel, P.H. (1981) Biochemistry, 20, 6961-6977. MEDLINE Abstract

49 Record, M.T. Jr, Lohman, T.M. and de Haseth, P. (1976) J. Mol. Biol., 107, 145-158. MEDLINE Abstract

50 Dolan, M.E., Oplinger, M. and Pegg, A. E., (1988) Carcinogenesis, 9, 2139-2143. MEDLINE Abstract

51 Liem, L.-K., Wong, C.W., Lim, A. and Li, B.F.L. (1993) J. Mol. Biol., 231, 950-959. MEDLINE Abstract

52 Liem, L.-K., Lim, A. and Li, B.F.L. (1994) Nucleic Acids Res., 22, 1613-1619. MEDLINE Abstract

53 Boiteux, S., de Oliveira, R.C. and Laval, J. (1985) J. Biol. Chem., 260, 8711-8715. MEDLINE Abstract

54 Souliotis, V. L., Giannopoulos, A., Koufakis, I., Kaila, S., Dimopoulos, C. and Kyrtopoulos, A. (1989) Carcinogenesis, 10, 1203-1208. MEDLINE Abstract

55 Scicchitano, D., Jones, R.A., Kuzmich, S., Gaffney, B., Lasko, D.D., Essigmann, J.M. and Pegg, A.E. (1986) Carcinogenesis, 7, 1383-1386. MEDLINE Abstract

56 Georgiadis, P., Smith, C.A. and Swann, P.F. (1991) Cancer Res., 51, 5843-5850. MEDLINE Abstract

57 Dolan, M.E., Pegg, A.E., Dumenco, L.L., Moschel, R.C. and Gerson, S.L. (1991) Carcinogenesis, 12, 2305-2310. MEDLINE Abstract

58 Pegg, A.E., Boosalis, M., Samson, L., Moschel, R.C., Byers, T.L., Swenn, K. and Dolan, M.E. (1993) Biochemistry, 32, 11998-12006. MEDLINE Abstract

59 Takahashi, M., Sakumi, K. and Sekiguchi, M. (1990) Biochemistry, 29, 3431-3436. MEDLINE Abstract

60 Gaffney, B.L. and Jones, R.A. (1989) Biochemistry, 28, 5881-5889. MEDLINE Abstract

61 Richardson, K.K., Crosby, R.M., Richardson, F.C. and Skopek, T.R. (1987) Mol. Gen. Genet., 209, 526-532. MEDLINE Abstract

62 Lukash, L.L., Boldt, J., Pegg, A.E., Dolan, M.E., Maher, V.M. and McCormick, J.J. (1991) Mutation Res., 250, 397-409.

63 Palombo, F., Kohfeldt, E., Calcagnile, A., Nehls, P. and Dogliotti, E. (1992) J. Mol. Biol., 223, 587-594. MEDLINE Abstract

64 Roy, R., Shiota, S., Kennel, S.J., Raha, R., von Wronski, M., Brent, T.B. and Mitra, S. (1995) Carcinogenesis, 16, 405-411. MEDLINE Abstract

65 Chan, C.L., Wu, Z., Ciardelli, T., Eastman, A. and Bresnick, E. (1993) Arch. Biochem. Biophys., 300, 193-200. MEDLINE Abstract

66 Elder, R.H., Tumelty, J., Douglas, K.T., Margison, G.P. and Rafferty, J.A. (1992), Biochem. J., 285, 707-709.

67 Morgan, S.E., Kelley, M.R. and Pieper, R.O. (1993) J. Biol. Chem., 268, 19802-19809. MEDLINE Abstract

68 Crone, T.M., Goodtzova, K., Edara, S. and Pegg, A.E. (1994) Cancer Res., 54, 6221-6227. MEDLINE Abstract

69 Dumenco, L.L., Warman, B., Hatzoglou, M., Lim, I.K., Abboud, S.L. and Gerson, S.L. (1989) Cancer Res., 49, 6044-6051. MEDLINE Abstract

70 Ostrowski, L.E., Pegram, C.N., von Wronski, M.A., Humphrey, P.A., He, X., Shiota, S., Mitra, S., Brent, T.P. and Bigner, D.D. (1991) Cancer Res., 51, 3339-3344. MEDLINE Abstract

71 Thomale J., Hochleitner, K. and Rajewsky, M.F. (1994) J. Biol. Chem., 269, 1681-1686.

72 Wang, Z., Buratowski, S., Svejotrup, J.O., Feaver, W.J., Wu, X., Kornberg, R.D., Donahue, T.F. and Friedberg, E.C. (1995) Mol. Cell. Biol., 15, 2288-2293. MEDLINE Abstract


Return

* To whom correspondence should be addressed
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. J. Rasimas, S. R. Kar, A. E. Pegg, and M. G. Fried
Interactions of Human O6-Alkylguanine-DNA Alkyltransferase (AGT) with Short Single-stranded DNAs
J. Biol. Chem., February 2, 2007; 282(5): 3357 - 3366.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Zang, Q. Fang, A. E. Pegg, and F. P. Guengerich
Kinetic Analysis of Steps in the Repair of Damaged DNA by Human O6-Alkylguanine-DNA Alkyltransferase
J. Biol. Chem., September 2, 2005; 280(35): 30873 - 30881.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. J. Rasimas, A. E. Pegg, and M. G. Fried
DNA-binding Mechanism of O6-Alkylguanine-DNA Alkyltransferase. EFFECTS OF PROTEIN AND DNA ALKYLATION ON COMPLEX STABILITY
J. Biol. Chem., February 28, 2003; 278(10): 7973 - 7980.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
P. E. Verdemato, J. A. Brannigan, C. Damblon, F. Zuccotto, P. C. E. Moody, and L.-Y. Lian
DNA-binding mechanism of the Escherichia coli Ada O6-alkylguanine-DNA alkyltransferase
Nucleic Acids Res., October 1, 2000; 28(19): 3710 - 3718.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
B. Singer and B. Hang
Nucleic acid sequence and repair: role of adduct, neighbor bases and enzyme specificity
Carcinogenesis, June 1, 2000; 21(6): 1071 - 1078.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Hang, J. Sagi, and B. Singer
Correlation between Sequence-dependent Glycosylase Repair and the Thermal Stability of Oligonucleotide Duplexes Containing 1,N6-Ethenoadenine
J. Biol. Chem., December 11, 1998; 273(50): 33406 - 33413.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Print PDF (124K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (17)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Bender, K
Right arrow Articles by Rajewsky, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bender, K
Right arrow Articles by Rajewsky, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?